Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code ANI

16. Specific lobbying issues

Issue: Reiterate the importance of animal models in medical research.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Natl Institutes of Health (NIH), Veterans Affairs - Dept of (VA)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

P.L. 116-37, Bipartisan Budget Act of 2019
Issue: Support efforts to Increase discretionary spending caps and non-defense discretionary spending for fiscal year 2021.

P.L. 116-260, Consolidated Appropriations Act, 2021, Division H, M, and N
H.R. 7614, Draft Senate, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021
H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021
Issues: Support increased funding for National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), Childrens Hospitals Graduate Medical Education (CHGME), Centers for Disease Control and Prevention (CDC), Hospital Preparedness Program, and biodefense, Ebola and public health preparedness programs. Oppose limitations on facilities and administrative reimbursement and on salary support. Maintain NIH salary cap at Executive Level II. Oppose reorganization of NIH and AHRQ without stakeholder input and deliberation. Oppose restrictions on fetal tissue research. Support animal research. Support funding for Health Resources and Services Administration (HRSA) workforce programs. Support funding for CDC Racial and Ethnic Approaches to Community Health program (REACH), Prevention Research Centers, and for research on gun violence. Support funding for Department of Education and federal student aid. Support funding to combat opioid epidemic and for new curricular materials. Support emergency funding and exemptions from discretionary spending caps. Support extensions of the period of disbursement for multi-year grants. Support ongoing investment in public health infrastructure. Urge completion by end of calendar year.
Issue: Support increased 302(b) funding allocations for Labor- HHS-Education and Commerce-Justice-Science Subcommittees.


P.L. 116-260, Consolidated Appropriations Act, 2021, Division B
H.R. 7667, Draft Senate, FY 2021 Commerce, Justice, Science, and Related Agencies Appropriations Act
H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021
Issues: Support funding for the National Science Foundation (NSF). Urge completion by end of calendar year.

P.L. 116-260, Consolidated Appropriations Act, 2021, Division J
H.R. 7609, Draft Senate, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2021
H.R.7608, State, Foreign Operations, Agriculture, Rural Development, Interior, Environment, Military Construction, and Veterans Affairs Appropriations Act, 2021
Issues: Support funding for Veterans Affairs medical research, research infrastructure, information technology, and community care. Oppose restrictions on use of canines in VA medical research. Oppose VA research funding rescissions. Support exemption from discretionary spending caps. Urge completion by end of calendar year.

P.L. 116-260, Consolidated Appropriations Act, 2021, Division G
H.R. 7612, Draft Senate, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2021
H.R.7608, State, Foreign Operations, Agriculture, Rural Development, Interior, Environment, Military Construction, and Veterans Affairs Appropriations Act, 2021
Issue: Support funding for Indian Health Service health professions, housing and medical equipment programs.

P.L. 116-260, Consolidated Appropriations Act, 2021, Division C
H.R. 7617, Department of Defense Appropriations Act, 2021
H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021
P.L. 116-283, William M. Thornberry National Defense Authorization Act for Fiscal Year 2021
Issue: Supporting funding for Department of Defense funding for medical personnel and infrastructure, as well as the Uniformed Services University of the Health Sciences (USUHS).

P.L. 116-260, Consolidated Appropriations Act, 2021, Division MM
P.L. 116-159 Continuing Appropriations Act, 2021 and Other Extensions Act
Issue: Support continuation of discretionary funding programs. Support the extension of mandatory appropriation funds for the National Health Service Corps, Community Health Centers, and Teaching Health Centers. Support fixes for Medicare Accelerated and Advance Payment Programs. Support repeal or a delay in the implementation of the Medicaid disproportionate share hospital (DSH) cuts.

Presidents Budget, FY 2022
Issue: Support funding for core public health infrastructure, VA Research, and HRSA Workforce Programs. Support funding for NSF related science priorities. Support sustained robust growth for NIH, emergency funding for NIH, and other medical research priorities.

P.L. 116-260, Consolidated Appropriations Act, 2021
PL 116-123, The Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020
PL 116 - 127, The Families First Coronavirus Response Act
P.L. 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act
P.L. 116-139, H.R. 266, The Paycheck Protection Program and Health Care Enhancement Act Interim Package
H.R. 6800, the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act
Draft Health, Economic Assistance, Liability Protection and Schools (HEALS) Act
S. 4322, Safely Back to School and Back to Work Act
S. 4320, Coronavirus Response Additional Supplemental Appropriations Act, 2020
H.R. 8406, The Heroes Act
S. 178 with Amendment No. 2652 HEALS Act
Draft Emergency Coronavirus Relief Act of 2020
Draft Bipartisan State and Local Support and Small Business Protection Act of 2020
Issue: Support emergency funding to provide relief for federal research agencies, investments in new COVID-19 research, funding for research infrastructure workforce and data science. Support extensions of the period of disbursement for multi-year grants. Support ongoing investment in public health infrastructure. Support funding for testing, contact tracing, vaccine development and distribution, and partnerships between academic medical centers and public health departments. Support funding for preparedness, PPE, and regional centers. Ensure access to research samples. Support funding for provider relief fund. Support funding for CDC, ASPR, NIH, HRSA, CMS, Department of Education, and other agencies Support emergency funding for medical schools. Support liability protections for providers and higher education institutions during COVID-19. Support fixes for Medicare Accelerated and Advance Payment Programs. Support nonprofit medical school, hospital, and physician practice eligibility for Main Street Lending Program.

Issue: Support unique mission of academic medicine.

H.R. 7308, Research Investment to Spark the Economy Act
S. 1585 Research Investment to Spark the Economy (RISE) Act
Issue: Support emergency funding to provide relief for federal research agencies and to extend administrative flexibilities.

Issue: Support continued funding support for World Health Organization activities

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Health Resources & Services Administration (HRSA), Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Veterans Affairs - Dept of (VA), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), Office of Science & Technology Policy (OSTP)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CPT

16. Specific lobbying issues

Issue: Educate Congress regarding technology transfer and the importance of the Bayh-Dole Act to the US patent system.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code EDU

16. Specific lobbying issues

H.R. 4674, College Affordability Act
S. 2557, Student Aid Improvement Act
S. 4257, Student Loan Repayment and FAFSA Simplification Act
S. 4322, Safely Back to School and Back to Work Act
Issues: Support affordable income driven repayment plans for borrowers. Oppose cuts to graduate/professional student loan and repayment plans, including Public Service Loan Forgiveness (PSLF) and elimination of GradPLUS loans.

P.L. 116-260, Consolidated Appropriations Act, 2021, Division FF
Draft Bipartisan Emergency COVID Relief Act of 2020
H.R. 6720, Student Loan Forgiveness for Frontline Health Workers Act
H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act
S.3763, Pandemic Responder Service Award Act
H.R. 6395, William M. (Mac) Thornberry National Defense Authorization Act of 2021
Issue: Support loan forgiveness for health care professionals.

P.L. 116-260, Consolidated Appropriations Act, 2021, Division FF
Draft Bipartisan Emergency COVID Relief Act of 2020
Issue: Support the extension of the suspension of student loan payments and interest accrual.

Issue: Support a change to the Department of Education Financial Aid Handbook redefining academic year for medical student loan disbursements.

Issue: Support single accreditation system for graduate medical education.

Issue: Educate Congress and the administration on the impact of medical education debt on career decisions like specialty choice.

H.R.103, Foreign Medical School Accountability Fairness Act of 2019
Issue: Support transparency for all international medical schools.

H.R. 3418, Protecting Our Students by Terminating Graduate Rates that Add to Debt Act
Issue: Support the reinstatement of federal direct Stafford loans to graduate and professional students.

Issue: Oppose efforts to stop the use of race as a factor in medical school admissions.

Issue: Support the repeal of Title IX campus sexual harassment regulations.

Issue: Oppose the Department of Educations Sec. 117 foreign gift reporting information collection request.

Issue: Oppose the Department of Educations investigation into Princeton Universitys anti-racism efforts.

Issue: Urge Department of Education to delay Sec. 117 and Title IX regulatory changes due to COVID-19.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Medicare Payment Advisory Commission (MedPAC), Education - Dept of, White House Office

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

Issue: Educate Congress and the administration on academic medicines missions, including education, research, patient care, GME, workforce, and physician shortages in rural and urban communities.

Draft Bipartisan Emergency COVID Relief Act of 2020

H.R. 6650, S. 3634, Health Heroes 2020 Act
S. 4055, Strengthening Americas Health Care Readiness Act
Issue: Support increased funding for the National Health Service Corps, and National Disaster Medical Service (NDMS) demonstration pilot.

Issues: Educate Congress and the administration about academic medicines response to the opioid epidemic. Support funding for training on substance use disorders, pain management, and safe prescribing practices. Support suspension of DATA waivers. Support continuation of telehealth flexibilities allowing authorized practitioners to prescribe buprenorphine.

P.L. 116-22, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
Issues: Support the Hospital Preparedness Program and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Support increased funding authorization levels.

Issue: Support high-quality affordable health insurance. Support programs and funds for safety-net providers.

Issue: Support measures to preserve and strengthen the 340B Drug Pricing Program and oppose efforts to reduce the scope of the program, including instituting a moratorium, increasing reporting requirements on covered entities, imposing user fees, changing the program from an up-front discount to a post-sale rebate, and not providing 340B discounts on covered drugs purchased at community pharmacies.

Issue: Oppose efforts to create new requirements for FQHC grantees that participate in the 340B program.

Issue: Oppose efforts to reduce OPPS reimbursements to hospitals for drugs acquired under the 340B program.

Issue: Oppose efforts to allow certain grandfathered health care plans to increase consumer cost sharing without losing their grandfathered status.

Issue: Oppose State relief and empowerment waivers that allow states to offer insurance plans that do not meet the requirements set forth under the Affordable Care Act.

Issue: Oppose efforts to expand the availability of Association Health Plans.

Issue: Oppose efforts to direct HHS to update the Medicare.gov Hospital Compare website.

Issue: Support increased interoperability and exchange of electronic health information and delayed enforcement of information blocking rule until comprehensive guidance is issued.

Issue: Oppose efforts to finalize two new mandatory alternative payment models, the Radiation Oncology Model and the End-stage Renal Disease Treatment Choices Model

Issue: Oppose burdensome regulation of Laboratory Developed Tests

S. 1895, Lower Health Care Costs Act
H.R. 3630, No Surprises Act
S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019
H.R. 3502, Protecting People From Surprise Medical Bills Act
Issues: Educate Congress on surprise medical bills and price transparency or disclosure. Support general principles for surprise medical bills draft legislation. Oppose statutory benchmark rate setting. Oppose Senate hospital/insurer contracting provisions and onerous reporting burden.

S. 1895, Lower Health Care Costs Act, Title IV
Issue: Prescription drug pricing, public health, maternal mortality, and health information technology.

Issue: Oppose restrictions on diversity training for federal grantees and employees.

Issue: Development of Enhanced Primary Care Pilot Act proposal

Issue: Educate Congress about medical education on nutrition, consent, implicit bias, and maternal health.

H.R. 6637, Health Equity and Accountability Act
Issue: Support programs to improve health equity and address social determinants of health.

Issue: Support initiatives of hospitals to promote affordable housing in local communities and eliminate other social determinants of health to improve health equity.

P.L. 116-260, Consolidated Appropriations Act, 2021
H.R. 4004, S. 2986 Social Determinants Accelerator Act of 2019
Issue: Support grants to address social determinants of health

Issue: Support congressional investment in the Centers for Medicare and Medicaid Innovation (CMMI) models to reduce maternal mortality and improve maternal health.

H.R. 4995 Maternal Health Quality Improvement Act of 2020
H.R. 4996 Helping MOMS Act of 2020
Issue: Support maternal health initiatives to expand coverage for postpartum women and expand demonstration project grants.

S. 3750/H.R. 6837, Medicare Accelerated and Advance Payment Improvement Act of 2020
Issue: Support improvements to the Medicare Accelerated and Advance Payment Programs.

Draft, firearm safety legislation
Issue: Support universal background checks, violence prevention programs, extreme risks protection orders, child access safety laws, and reinstating assault weapons ban.

H.R. 8, Bipartisan Background Checks Act of 2019
Issue: Support universal background checks

Issue: Support aligning 42 CFR Part 2 regulations with the Health Insurance Portability and Accountability Act (HIPAA) for the purposes of treatment, payment, and healthcare operations.

S. 4349/H.R. 8094, Dr. Lorna Breen Health Care Provider Protection Act
Issue: Support grants directed at improving physician burnout and well-being.

P.L. 116-260, Consolidated Appropriations Act, 2021
P.L. 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020
P.L. 116-127, Families First Coronavirus Response Act
P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES) Act H.R.6379, Take Responsibility for Workers and Families Act
H.R. 6800, the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act
Draft Health, Economic Assistance, Liability Protection and Schools (HEALS) Act
S. 178 with Amendment No. 2652 HEALS Act
S. 4322, Safely Back to School and Back to Work Act
S. 178, Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act
H.R. 8406, The Heroes Act
Draft Emergency Coronavirus Relief Act of 2020
Draft Bipartisan State and Local Support and Small Business Protection Act of 2020
Issues: Support emergency supplemental funding and policies for federal agencies to support coronavirus preparedness, response, relief, vaccine development and distribution, and testing and contact tracing. Ensure access to research samples. Support funding for and provide recommendations for disbursement of provider relief fund. Support revised Medicare and Medicaid reimbursement policies and increased provider flexibility. Support improvements to the Medicare Accelerated and Advance Payment Programs. Support inclusion of Medicare-supported graduate medical education positions. Support fixes to Medicare GME Rural Training Track programs. Support Medicare GME per resident amount and cap-setting technical corrections and administrative relief. Support an increase in the Federal Medicaid Assistance Program. Support for current telehealth waivers to be made permanent. Support for extension of Medicare sequester moratorium. Support changes to CY 2021 Physician Fee Schedule evaluation and management payments. Provide recommendations on personal protective equipment, testing, social distancing, clinical care, and other COVID related preparedness and response efforts of the federal government. Avoid imposing standards that would encourage depletion of scarce PPE and other resources. Support enhanced national COVID-19 data collection to better address health disparities. Support public health infrastructure. See other additions under BUD.

Issue: Support extension of public health emergency declaration.

Issue: Provide feedback on COVID-19 and pandemic response centers of excellence legislation.

Issue: Support establishment of regional pandemic response centers, stronger linkages between public health and academic medicine, and the role of medical students in administering covid vaccines.

Issue: Urge establishment and implementation of robust national COVID-19 testing strategy and functional and transparent supply chain. Urge CDC to update testing guidelines.

Issue: Describe medical education approach on womens health and support efforts to promote trauma-informed care.

Issue: Support science and data driven approach to HHS and EPA decision making.

Issue: Support CDC mission

S 4248 / HR 7618 COVID-19 Bias and Anti-Racism Training Act
Issue: Support grant for anti-racism training in health professions programs.
H.R. 8017, Mobile Options for Testing In Our Neighborhoods (MOTION) Act
Issue: Support grants for mobile COVID-testing units.

S. 4160, To enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
Issue: Support protections for hospitals that participate in the 340B Drug Pricing Program to temporarily allow them to remain eligible for the program.

H.R. 8283 S. 4421, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act
Issue: Support for a temporary uniform licensing standard for all practitioners in all states throughout a national emergency.

Issue: Support the rescission of the Department of Homeland Securitys Public Charge rule.

Issue: Participate in Resilient American Communities initiative
S. 4740 Public Health Infrastructure Saves Lives Act
Issue: Support investments in core public health infrastructure.

Issue: Rescind the Executive Order on Creating Schedule F in the Excepted Service.

Issue: Rescind Executive Orders 13771 and 13777, and support re-implementation of directives under Executive Order 13563, Improving Regulation and Regulatory Review.

Issue: Support establishment of a Presidential Bioethics Commission.

Issue: Support ensuring patients are put first and that conscience protections align with medical professionalism standards.

Issue: Support prompt establishment of the Research Policy Board and implementation of the additional reform efforts required by Section 2034 of the 21st Century Cures Act (P.L. 114-255).

Issue: Support increased interoperability and exchange of electronic health information. Support delay of enforcement beyond April 2021.

Issue: Support identification of specific federal regulations for review for disproportionate administrative impacts.

Issue: Support independence of the US Food and Drug Administration.

Issue: Support FDA rulemaking to harmonize protection of human research subjects.

Issue: Support promotion of data sharing and clinical trials results reporting.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), Health Resources & Services Administration (HRSA), Centers For Medicare and Medicaid Services (CMS), Natl Institutes of Health (NIH), Substance Abuse & Mental Health Services Administration (SAMHSA), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), Executive Office of the President (EOP), Office of Natl Drug Control Policy (NDCP), White House Office, Federal Emergency Management Agency (FEMA), Office of the Vice President of the United States, Homeland Security - Dept of (DHS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code IMM

16. Specific lobbying issues

H.R. 6, The American Dream and Promise Act of 2019
S. 874, The Dream Act of 2019
Issue: Support policies allowing undocumented students to attend U.S. medical schools and graduate medical education. Oppose rescission of Deferred Action for Childhood Arrivals (DACA) executive action without permanent replacement. Support Dreamer eligibility for federal student loans.

Issue: Oppose repeal of DACA Executive Action

S. 948 / H.R. 2895, Conrad State 30 and Physician Access Reauthorization Act
Issue: Support reauthorization and expansion of the Conrad 30 program, and improvements to physician immigration

Issue: Support policies to ensure timely and predictable processing for immigration of academic medicine community

Issue: Support extending duration of stay for physicians on visas during the COVID pandemic, expediting change of status and visa renewals, and expedite visa approvals for medical residents entering the country.

Issue: Oppose travel ban indefinitely bars individuals from certain countries from entering the United States based on their nationality.

Issue: Oppose Duration of Status rule which provides a specific end date for certain nonimmigrant visa categories, including F-1 student and J-1 exchange visitor visas.

Issue: Support the rescission of H-1B Prevailing Wage rules.

Issue: Oppose policies limiting entry of medical students, residents, researchers, and health professionals to the U.S. on the F-1, J-1, and H-1B visas.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Homeland Security - Dept of (DHS), U.S. Citizenship & Immigration Services (USCIS), White House Office, Executive Office of the President (EOP), State - Dept of (DOS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MED

16. Specific lobbying issues

P.L. 114-255, 21st Century Cures Act, Division A

Issue: Support implementation of 21st Century Cures Act, including the Innovation Fund, increased funding for medical research, reducing administrative and regulatory burden on scientists and research institutions, and supporting young investigators.

H.R. 6417, Protecting Cures Act of 2020
Issue: Support legislation to reiterate HHSs obligation to fund scientifically meritorious research that meets specified criteria.

S. 3161, National Biomedical Research Act
Issue: Support legislation to establish a Biomedical Innovation Fund.

H.Res. 1125, Expressing support for prioritizing racial and ethnic diversity in clinical trials for therapies, diagnostics, and vaccines for COVID-19.
Issue: Support clinical trials diversity.

Issue: Support ethical use of fetal tissue in medical research.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), White House Office

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

Issue: Support repeal or a delay in the implementation of the Medicaid disproportionate share hospital (DSH) cuts

Issue: Educate Congress on concerns related to potentially burdensome Medicaid supplemental payment reporting proposals

Issue: Educate Congress on the negative impact of the proposed Medicaid Fiscal Accountability Regulation (MFAR) and urge the administration to withdraw or delay the proposal

Issue: ACA Medicaid expansion. Maintain commitment to match State spending on medical care for Medicaid beneficiaries without limits, caps, or block grants. Maintain and enforce network adequacy requirements and mandate sufficient payments to providers.

S. 1343, Maximizing Outcomes for Moms through Medicaid Improvement and Enhancement of Services (MOMMIES) Act Issue: Support expansion of Medicaid and CHIP coverage for postpartum women from current 90 days to 1 year.

S. 585, States Achieve Medicaid Expansion (SAME) Act of 2019
Issue: Support legislation to allow states that expanded Medicaid after 2014 to receive the same full federal matching funds as states that previously expanded Medicaid under the Affordable Care Act

H.R. 1763 / S. 348, Resident Physician Shortage Reduction Act of 2019
Issue: Support additional Medicare funding for graduate medical education
H.R. 3414 / H.R. 2439, Opioid Workforce Act
Issue: Support additional Medicare funding for graduate medical education for addiction medicine, addiction psychiatry, and pain medicine residency programs

S. 289, Rural Physician Workforce Production Act of 2019
Issue: Oppose legislation redesigning Medicare GME payment formulas that reduce current DGME/IME payments to teaching hospitals

H.R. 8892, Rural-Urban Physician Workforce Act of 2020
Issue: Support improvements to Rural Training Track programs.

H.R.1358, Advancing Medical Resident Training in Community Hospitals Act of 2019
H.R. 3417, Beneficiary Education Tools, Telehealth, and Extenders Reauthorization (BETTER) Act
Issue: Support Medicare Graduate Medical Education (GME) per resident amount and cap-setting technical corrections and administrative relief.

Issues: Support lifting cap on number of residents Medicare will count when determining teaching hospitals' Medicare Direct Graduate Medical Education (DGME) and Indirect Medical Education (IME) payments

Issue: Oppose reduction of Medicare GME/IME payments

Issue: Oppose redesign of Medicare Indirect Medical Education financing and redistribution.


Issue: Oppose reduction in Medicare hospital outpatient department reimbursement.

Issue: Oppose Medicare hospital cuts

Issue: Oppose overly burdensome Medicaid GME transparency language.

Issue: Support technical correction to increase access to physician services in rural communities by allowing teaching hospitals to count resident time spent in critical access hospitals for purposes of Medicare GME payments.

H.R. 5432, Medical Education for a Diverse America Act
Issue: Ensure that time medical residents spend in unconscious bias training is counted toward the determination of FTE for Medicare GME Issue: Educate Congress on role of academic medicine as it relates to price transparency or disclosure initiatives

H.R. 3107, Improving Seniors Timely Access to Care Act of 2019
Issue: Support protecting patients from delays in care by streamlining and standardizing prior authorization under the Medicare Advantage program and providing program oversight and transparency

Issue: Modify CMS Hospital Compare Star Ratings to allow stakeholders time to work together to address concerns with methodology. Support inclusion of sociodemographic status as part of quality programs

HHS Rebate Rule
Medicare Part D benefit re-design
Issue: Support policies to reduce prescription drug prices

Issue: Support implementation of the 21st Century Cures Act (Cures) interoperability and health data sharing provisions.

Issue: Support changes and improvements to the Medicare Shared Savings Program.

Issue: Support necessary changes and improvements to the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA)

S. 1343, Maximizing Outcomes for Moms through Medicaid Improvement and Enhancements of Services (MOMMIES) Act
H.R. 4996, Helping Medicaid Offer Maternity Services (MOMS) Act of 2020
Issue: Support expansion of Medicaid coverage for postpartum women.

H.R. 8702 Holding Providers Harmless from Medicare Cuts During COVID-19 Act of 2020
Issue: Support relief for providers from pending evaluation and management cuts included in the CY 2021 Physician Fee Schedule (PSF) rule.

H.R. 8840 Medicare Sequester COVID Moratorium Act
Issue: Support extension of Medicare sequester.

Issue: Oppose efforts by states to impose work or other community engagement activities as a requirement for continued Medicaid eligibility or coverage for certain Medicaid beneficiaries.

Issue: Support making permanent the CMS policy allowing teaching physicians to provide supervision via real-time, interactive audio/video technology to meet resident supervision requirements.

Issue: Support making permanent the interim final rule that allows hospitals that unknowingly trigger their Medicare GME caps and per resident amounts to not have that happen and instead retain the ability to build a new resident cap / PRA so long as the cap / PRA is not above a minimum amount.

Issue: Support CMS introducing new regulations to make permanent the interim final rule that ensures teaching hospitals that increased their number of inpatient beds to accommodate the surge in patients during the public health emergency to not have their Indirect Medical Education (IME) payments reduced by CMS.

Issue: Oppose CMS hospital price transparency rule.

Issue: Oppose site-neutral expansion to excepted off-campus provider-based departments (PBDs).

Issue: Support waiving budget neutrality requirements associated with the E/M code changes or temporarily holding harmless physicians and other health care professionals.

Issue: Oppose Hospital co-location draft guidance.

Issue: Oppose finalizing proposed rule for Medicare Coverage of Innovative Technology (MCIT) and definition of reasonable and necessary.

Issue: Oppose enforcement of linking Medicare Conditions of Participation (CoP) compliance with requiring that hospitals report 38 COVID-19 related measures.

Issue: Support continuation of the 3-Day Skilled Nursing Facility (SNF) Stay waiver after the conclusion of the COVID-19 public health emergency.

Issue: Oppose finalizing prior authorization policy in CY 2020 for certain HOPD services and in CY 2021 to include new service categories.

Issue: Oppose efforts to remove five exclusion criteria that would allow over 270 new procedures to be performed in ASC settings in CY 2021.

Issue: Oppose the elimination of the Inpatient Only List over a three-year period

Issue: Oppose policy of incorporating revenue distinctions into the Medicare Shared Savings Program.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Medicare Payment Advisory Commission (MedPAC), Health & Human Services - Dept of (HHS), White House Office

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code SCI

16. Specific lobbying issues

Issue: Support reducing administrative and regulatory burden on scientists and research institutions.

Issue: Support efforts to promote research integrity, address potential for foreign influence in science, and address harassment in science.

Issue: Support the use of a competitive peer review process for federal research grants and programs

H.R. 3038, Securing American Science and Technology Act
S. 2133, Secure American Research Act of 2019
H.R. 2500, National Defense Authorization Act for Fiscal Year 2020
Issue: Support efforts to address foreign influence on science, including stakeholder engagement from institutions of higher education.

S. 3997, Safeguarding American Innovation Act
Issue: Support JCORE efforts to address foreign influence on science and ensure a balanced approach.

Issue: Explore opportunities to improve research with cannabinoids.

Issue: Urge extension of COVID-19 related administrative flexibilities

HR 7308 / S 4286, Research Investment to Spark the Economy Act
Issue: Support research relief at federal science agencies due to COVID pandemic.

Issue: Support house science committee chair request for NASEM study on impact of racism in academia.

H.R. 4373, Bioeconomy Research and Development Act of 2020
Issue: Describe implications for medical research enterprise.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office, Natl Institutes of Health (NIH), Natl Science Foundation (NSF), Health & Human Services - Dept of (HHS), Office of Science & Technology Policy (OSTP), Office of Management & Budget (OMB)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code VET

16. Specific lobbying issues

Issue: Educate Congress on the importance of the VAs academic affiliates to improve veteran care through clinical, research, and education partnerships. Educate Congress on the national physician workforce shortages impact on VA

Issue: Support maintaining VA medical services in conjunction with VA community care.

Issue: Support increased investments in IT and research infrastructure for the VA research program; Support Paperwork Reduction Act exemption for VA researchers.

17. House(s) of Congress and Federal agencies Check if None

Veterans Affairs - Dept of (VA), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Office of Management & Budget (OMB), White House Office

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TAX

16. Specific lobbying issues

Issue: Support reducing administrative and regulatory burden on scientists and research institutions.

Issue: Support efforts to promote research integrity, address potential for foreign influence in science, and address harassment in science.

Issue: Support the use of a competitive peer review process for federal research grants and programs

H.R. 3038, Securing American Science and Technology Act
S. 2133, Secure American Research Act of 2019
H.R. 2500, National Defense Authorization Act for Fiscal Year 2020
Issue: Support efforts to address foreign influence on science, including stakeholder engagement from institutions of higher education.

S. 3997, Safeguarding American Innovation Act
Issue: Support JCORE efforts to address foreign influence on science and ensure a balanced approach.

Issue: Explore opportunities to improve research with cannabinoids.

Issue: Urge extension of COVID-19 related administrative flexibilities

HR 7308 / S 4286, Research Investment to Spark the Economy Act
Issue: Support research relief at federal science agencies due to COVID pandemic.

Issue: Support house science committee chair request for NASEM study on impact of racism in academia.

H.R. 4373, Bioeconomy Research and Development Act of 2020
Issue: Describe implications for medical research enterprise.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Treasury - Dept of, Internal Revenue Service (IRS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
No Yes